Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.20p
   
  • Change Today:
      0.007p
  • 52 Week High: 1.22p
  • 52 Week Low: 0.20p
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 1,044,568
  • Market Cap: £4.36m
  • Beta: 0.25

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

Traded Action Notifier PriceAmountValue
14-Oct-25 Buy Edward Wardle 0.18p 7,342,296 £12,849.02

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
14-Oct-25 Buy Edward Wardle 0.18p 7,342,296 £12,849.02

Director Shareholdings

Notifier Holding Value*
Edward Wardle 7,342,296 £14,910
Huw Jones 3,184,793 £6,468
Toni Hänninen 1,000,000 £2,031

Major Shareholders

Notifier** Holding Value*
Northern Standard Limited 430,069,568 £873,372
TRACARTA LIMITED 422,727,272 £858,462
First Equity Limited 179,000,000 £363,508
T and I Limited 160,000,000 £324,923
Oberon Investments Limited 80,475,000 £163,426
Spreadex Ltd 80,009,545 £162,481
Andrew Leach 80,000,000 £162,462
Simon Gibeon 71,400,000 £144,997
Rathbones Investment Management Ltd 25,789,246 £52,372
Sarum Investment SICAV Plc 25,700,000 £52,191
Octopus Investments Nominees Limited 21,875,000 £44,423
Octopus Investments Nominees Limited 21,875,000 £44,423
Vulpes Investment Management Pte Ltd 20,554,191 £41,741
InterTrader Limited 16,560,033 £33,630
Seneca Partners Limited 16,301,456 £33,104
North West Fund (Biomedical) LP 16,186,446 £32,871
Richard Griffiths and family 14,408,000 £29,259
AXA Framlington Investment Management Limited 13,399,724 £27,212
Chelverton Asset Management 12,500,000 £25,385
RAB Capital 8,750,000 £17,769
David and Monique Newlands 8,314,815 £16,886
Newlands Capital 8,314,815 £16,886
Ali Mortazavi 3,400,000 £6,905
PARTNERS INVESTMENT COMPANY LLP 3,114,089 £6,324
Letzone Limited 2,664,000 £5,410
Beaufort Securities Limited 2,457,568 £4,991
South Yorkshire Investment Capital Fund LP 1,394,550 £2,832

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.20p
Change Today 0.007p
% Change -3.30 %
52 Week High 1.22p
52 Week Low 0.20p
Volume 1,044,568
Shares Issued 2,148.96m
Market Cap £4.36m
Beta 0.25

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average
90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average
Price Trend
86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average
72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 03-Nov-2025

Time Volume / Share Price
08:33 139,676 @ 0.20p
08:18 1,650 @ 0.22p
08:02 4,396 @ 0.20p
08:01 504,774 @ 0.22p
08:00 250,000 @ 0.22p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page